USPTO serial 86693001
BTG PASSPORT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 5, 2016
- Examiner
- BOULTON, KELLY F
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BTG PASSPORT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
PROTHERICS MEDICINES DEVELOPMENT LIMITED
London, GB
Other trademarks owned by PROTHERICS MEDICINES DEVELOPMENT LIMITED
London, GB
London, GB
London, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan A. Hyman
Jonathan A. Hyman Knobbe Martens Olson & Bear LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Education services, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; teaching services in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; training services in the use and operation of medical devices, medical ultrasound apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online and telephonic instruction and courses in the fields of health and medical issues; providing computer, electronic and online databases featuring information about medical education in the field of medical device and pharmaceutical industry; Providing on-line non-downloadable publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; Providing on-line non-downloadable publications in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing educational electronic online databases featuring information about medical education for medical purposes in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; organization of educational symposia in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; organization of educational conferences and symposia in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; clinical paper library services; on-line clinical library services; image library services; on-line image library services; providing, arranging, organizing and conducting educational courses, lectures, seminars, working groups, research groups and workshops in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; providing, arranging, organizing and conducting educational courses, lectures, seminars, working groups, research groups and workshops in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; arranging, organizing and conducting educational conventions, congresses, conferences and exhibitions in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, and medicine; arranging, organizing and conducting educational conventions, congresses, conferences and exhibitions in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; Providing a website featuring online educational resources, namely, non-downloadable publications in the nature of case study articles and materials and non-downloadable audio and video presentations in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; consultancy, advisory and information services relating to or connected with all the aforementioned services | SECTION 8 - CANCELLED | — |
| 044 | Medical and healthcare services; medical services relating to ultrasound waves to enhance drug delivery and medically activate drugs; medical services in the nature of dissolution of thrombotic blood clot material using catheters; medical, namely, diagnosis, assessment, treatment and aftercare in the fields of sclerotherapy, phlebology, angiology, proctology, interventional oncology, ablation of tumours using embolic beads, ablation of tumors using embolic radioactive beads, ablation of tumors using embolic drug eluting beads and emphysema, and in connection with varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilization treatment; medical analysis for the diagnosis and treatment of cancer, tumors, emphysema, sclerotherapy, phlebology, angiology, proctology, varicose veins, arterio-venous malformations, oesophageal varices, sterilization treatment, circulatory system conditions, and pulmonary and thoracic conditions; pharmacy advice in the nature of pharmaceutical and medical device advice; medical services for diagnosis in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilization treatment; medical health assessment services, namely, medical diagnosis of diseases and conditions in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment. medical treatment of diseases and conditions in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; medical after care services in the fields of emphysema, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilization treatment; advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and providing health advice and information services; conducting health assessment surveys, health risk assessment surveys, and treatment outcome surveys, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information and health advice and information services; healthcare consultancy services; consultancy services relating to medical treatment; providing medical information, analysis and advice relating to pharmaceutical use, medical treatments, and healthcare via a computer database or the Internet; providing medical information regarding medicine, medical treatment, patient care, pharmaceuticals, prescription drugs, medical devices, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare via a website; Providing medical and health care information by databases, text messages, computer and communication networks; information services relating to healthcare and medical treatment; healthcare consultancy services, namely, providing a hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by hotline services; providing health and medical information by hotline services; advisory services relating to health and healthcare; medical equipment rental; advisory services relating to medical apparatus, instruments and preparations; advisory services relating to medical services; providing medical advisory, consultancy and information services relating to the aforesaid services; medical services relating to treatment of snakebite envenomation, digoxin or digitalis toxicity, methotrexate toxicity, fluorouracil toxicity and chemotherapy toxicity; providing medical information in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PROTHERICS MEDICINES DEVELOPMENT LIMITED
- Other trademarks owned by BTG International Limited
- Other trademarks owned by BTG International Limited
- Other trademarks owned by BTG International Limited
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named BTG PASSPORT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 20, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Apr 12, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 12, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 12, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 12, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 12, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 12, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 30, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 30, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 30, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 30, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 5, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 14, 2021 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 29, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 29, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 29, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 29, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 5, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 19, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 30, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 8, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 8, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 8, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 8, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 16, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 16, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2016 | ALIE | ASSIGNED TO LIE | — |
| Feb 3, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 3, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 3, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 20, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 17, 2015 | NWAP | NEW APPLICATION ENTERED | — |